通冠丸治疗不稳定型心绞痛40例
Western Journal of Traditional Chinese Medicine(2013)
Abstract
目的:观察通冠丸对不稳定型心绞痛(UA)患者血清超敏C反应蛋白(hs-CRP)、同型半胱氨酸(HCY)的影响。方法:将80例患者随机分为治疗组、对照组各40例。2组均给予西药常规治疗,治疗组在此基础上加用通冠丸,20丸/次,口服,3次/d。治疗4周后观察心绞痛临床疗效及HCY、hs-CRP的水平变化。结果:总有效率治疗组为90.0%,对照组为82.5%,2组无明显差异(P>0.05)。2组治疗后HCY、hs-CRP值均明显下降(P<0.05),治疗组下降更显著(P<0.05)。结论:通冠丸联合西药常规治疗UA临床疗效显著,可显著降低患者血清HCY和hs-CRP水平。
MoreTranslated text
Key words
angina pectoris,TongGuanWan,hypersensitive C-reactive protein,homocysteine
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined